Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
Shopping Cart: ( empty )
You are here: Home > Journals > SH > SH05027
RESEARCH ARTICLE
Contents Vol 3(1)

The price of guidelines: revising the national guidelines for managing Australian women with abnormal Pap smears

Heather Mitchell
+ Author Affiliations
- Author Affiliations

Victorian Cytology Service, PO Box 178, Carlton South, VIC 3053, Australia. Email: hmitchel@vcs.org.au

Sexual Health 3(1) 53-55 https://doi.org/10.1071/SH05027
Submitted: 10 May 2005  Accepted: 21 July 2005   Published: 20 February 2006

Abstract

Australia utilises nationally approved guidelines for managing women with abnormal Pap smears. The guidelines were recently revised using the process designated by the National Health and Medical Research Council. Revising the guidelines was protracted and controversial. This paper explores the reasons for the difficulties encountered and queries the cost of undertaking such work.


References


[1] Muir Gray JA . Evidence-based healthcare. 2nd edn. Edinburgh: Churchill Livingstone; 2001.

[2] Screening to prevent cervical cancer: guidelines for the management of women with screen detected abnormalities. Canberra: AGPS; 2004.

[3] National Health and Medical Research Council (NHMRC). A guide to the development, implementation, and evaluation of clinical practice guidelines. Canberra, NHMRC; 1999.

[4] Ferlay J , Bray F , Pisani P , Parkin DM . GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0. Available online at: www-dep.iarc.fr [verified February 2006].

[5] Hirst GH,  Ward JE. Clinical practice guidelines: reality bites. Med J Aust 2000; 172 287–91.
| PubMed |

[6] Edmonds JP,  Day RO,  Bertouch JV. The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors. Med J Aust 2002; 176 332–4.
| PubMed |